Everlon Financials Ltd
EVERFINEverlon Financials Ltd
EVERFIN
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 10.38 | 4.57 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 39.70 | 6.90 | 0.71% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
0
Peers
Compare with peersKPR Mill Ltd
Vedant Fashions Ltd
Aditya Birla Real Estate Ltd
Swan Energy Ltd
Trident Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 31.58 | 39.30 | 36.78 | 39.66 | 37.37 | 34.17 | 37.38 | 5.29 | 10.23 | 12.18 | ||||||||||
Raw Materials | — | — | — | — | — | — | — | — | — | 3.23 | ||||||||||
| Power & Fuel Cost | — | — | — | — | — | — | — | — | — | |||||||||||
| Employee Cost | 0.60 | 0.67 | 0.63 | 0.72 | 1.03 | 1.02 | 1.36 | 0.16 | 0.17 | |||||||||||
| Selling & Administrative Expenses | — | — | — | — | — | — | — | — | — | |||||||||||
| Operating & Other expenses | 30.65 | 38.23 | 35.64 | 39.08 | 35.95 | 32.61 | 33.49 | 2.97 | 0.91 | |||||||||||
EBITDA | 0.33 | 0.40 | 0.51 | -0.14 | 0.39 | 0.54 | 2.53 | 2.16 | 9.15 | 8.95 | ||||||||||
| Depreciation/Amortization | 0.23 | 0.22 | 0.22 | 0.25 | 0.23 | 0.22 | 0.22 | 0.07 | 0.08 | 0.09 | ||||||||||
| PBIT | 0.10 | 0.18 | 0.29 | -0.39 | 0.16 | 0.32 | 2.31 | 2.09 | 9.07 | 8.86 | ||||||||||
| Interest & Other Items | — | — | — | — | — | — | — | — | — | — | ||||||||||
| PBT | 0.10 | 0.18 | 0.29 | -0.39 | 0.16 | 0.32 | 2.31 | 2.09 | 9.07 | 8.86 | ||||||||||
| Taxes & Other Items | 0.02 | 0.04 | 0.06 | 0.00 | 0.00 | 0.22 | 0.20 | 0.74 | 1.06 | 0.30 | ||||||||||
| Net Income | 0.08 | 0.14 | 0.23 | -0.39 | 0.16 | 0.10 | 2.11 | 1.35 | 8.01 | 8.56 | ||||||||||
| EPS | 0.17 | 0.25 | 0.41 | -0.69 | 0.28 | 0.18 | 3.74 | 2.40 | 13.55 | 13.81 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Consumer DiscretionaryTextiles
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Everlon Financials Ltd | 11.09 | 4.57 | — |
| KPR Mill Ltd | 43.37 | 8.02 | 0.49% |
| Vedant Fashions Ltd | 80.78 | 20.89 | 0.62% |
| Aditya Birla Real Estate Ltd | 612.82 | 7.56 | 0.18% |
Price Comparison
Compare EVERFIN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
EVERFIN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Everlon Financials declined 51.14% to Rs 0.43 crore in the quarter ended September 2024 as against Rs 0.88 crore during the previous quarter ended September 2023. Sales declined 24.66% to Rs 3.36 crore in the quarter ended September 2024 as against Rs 4.46 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.364.46 -25 OPM %16.9629.60 - PBDT0.551.34 -59 PBT0.531.32 -60 NP0.430.88 -51 Powered by Capital Market - Live
Everlon Financials will hold a meeting of the Board of Directors of the Company on 24 October 2024.Powered by Capital Market - Live
Everlon Financials announced that the Annual General Meeting (AGM) of the company will be held on 16 September 2024.Powered by Capital Market - Live
Net profit of Everlon Financials rose 112.90% to Rs 1.98 crore in the quarter ended June 2024 as against Rs 0.93 crore during the previous quarter ended June 2023. Sales rose 212.41% to Rs 4.53 crore in the quarter ended June 2024 as against Rs 1.45 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales4.531.45 212 OPM %45.7095.86 - PBDT2.051.41 45 PBT2.031.40 45 NP1.980.93 113 Powered by Capital Market - Live
Everlon Financials will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
COVID-19: Everest Organics starts making ingredient for Merck’s molnupiravir drug
India’s Everest Organics starts making ingredient for Merck’s COVID-19 pill
Everest Organics ends 15% higher on development of Molnupiravir, a new API to treat Covid-19
Everest Organics standalone net profit rises 124.31% in the December 2020 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -23.74%, vs industry avg of 2.96%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.03% to 0.01%